Abstract：
UNASSIGNED: The current treatment options for T1b glottic carcinoma often lead to poor treatment outcomes or voice quality.
UNASSIGNED: This study evaluates the therapeutic efficacy of horizontal middle partial laryngectomy with cricothyroidopexy (HMPL-CTP) for stage T1b glottic carcinoma.
UNASSIGNED: A retrospective analysis was conducted on 73 patients with T1b glottic carcinoma. The patients were categorized into three groups: Group A (n = 22) underwent transoral laser microsurgery (TLMS), Group B (n = 21) received frontolateral vertical partial laryngectomy (FVPL), and Group C (n = 30) underwent HMPL-CTP. The study analyzed the 5-year overall survival rate (OS), recurrence rate, phonatory status, and incidence of laryngeal stenosis.
UNASSIGNED: Voice quality scores varied significantly in the three groups, while the 5-year OS were similar. The local recurrence rate is higher in Group A than in the other two groups. The laryngeal stenosis rate in Group B is higher than in Groups A and C. Adhesions in the anterior commissure were observed in 18 cases in Group A and nine cases in Group C.
UNASSIGNED: HMPL-CTP demonstrates efficacy as a treatment for stage T1b glottic carcinoma, offering favorable preservation of laryngeal function and minimal complications.
UNASSIGNED: This study evaluates the therapeutic efficacy of horizontal middle partial laryngectomy with cricothyroidopexy (HMPL-CTP) for stage T1b glottic carcinoma.
UNASSIGNED: A retrospective analysis was conducted on 73 patients with T1b glottic carcinoma. The patients were categorized into three groups: Group A (n = 22) underwent transoral laser microsurgery (TLMS), Group B (n = 21) received frontolateral vertical partial laryngectomy (FVPL), and Group C (n = 30) underwent HMPL-CTP. The study analyzed the 5-year overall survival rate (OS), recurrence rate, phonatory status, and incidence of laryngeal stenosis.
UNASSIGNED: Voice quality scores varied significantly in the three groups, while the 5-year OS were similar. The local recurrence rate is higher in Group A than in the other two groups. The laryngeal stenosis rate in Group B is higher than in Groups A and C. Adhesions in the anterior commissure were observed in 18 cases in Group A and nine cases in Group C.
UNASSIGNED: HMPL-CTP demonstrates efficacy as a treatment for stage T1b glottic carcinoma, offering favorable preservation of laryngeal function and minimal complications.
摘要：
■目前T1b声门型喉癌的治疗方案往往导致不良的治疗结果或语音质量。
■本研究评估了水平中喉部分切除术联合环甲切除术（HMPL-CTP）治疗T1b期声门型喉癌的疗效。
■对73例T1b声门型喉癌患者进行回顾性分析。将患者分为三组：A组（n=22）接受经口激光显微手术（TLMS），B组（n=21）接受额外侧垂直喉部分切除术（FVPL），C组（n=30）行HMPL-CTP。该研究分析了5年总生存率(OS)，复发率,语音状态，和喉部狭窄的发生率。
■三组的语音质量得分差异很大，而5年OS相似。A组的局部复发率高于其他两组。B组喉狭窄率高于A组和C组。A组18例，C组9例，观察到前连合粘连。
■HMPL-CTP显示出治疗T1b期声门癌的疗效，提供良好的喉功能和最小的并发症。
■本研究评估了水平中喉部分切除术联合环甲切除术（HMPL-CTP）治疗T1b期声门型喉癌的疗效。
■对73例T1b声门型喉癌患者进行回顾性分析。将患者分为三组：A组（n=22）接受经口激光显微手术（TLMS），B组（n=21）接受额外侧垂直喉部分切除术（FVPL），C组（n=30）行HMPL-CTP。该研究分析了5年总生存率(OS)，复发率,语音状态，和喉部狭窄的发生率。
■三组的语音质量得分差异很大，而5年OS相似。A组的局部复发率高于其他两组。B组喉狭窄率高于A组和C组。A组18例，C组9例，观察到前连合粘连。
■HMPL-CTP显示出治疗T1b期声门癌的疗效，提供良好的喉功能和最小的并发症。
